Get the latest news, insights, and market updates on all tickers. Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Samsung Shares Surge to Record After Report on Higher Chip Price
The chipmaker’s stock rose as much as 5.4% on Korea Exchange, as the market reopened following a three-day holiday. Samsung is looking to price its HBM4 at around $700 per unit, according to Chosun Ilbo newspaper. Samsung declined to comment on the media report. Feb 19, 2026 - $AAPL
Apple stock quietly moves on a surprising Al hardware bet
Apple’s AI story just got a lot more concrete, and the stock is already reacting. Shares of Apple rose after investors latched onto reports that the company is accelerating work on three new AI‑driven wearables built around Siri: smart glasses, a small pendant, and camera‑equipped AirPods. “$AAPL ... Feb 19, 2026 - $AAPL
Evercore Notes AbbVie Inc.’s (ABBV) Tremfya Gains Market Share, But Future Earnings Growth May Be Limited
AbbVie Inc. (NYSE:ABBV) is among the 7 Most Promising Psychedelic Stocks According to Hedge Funds. AbbVie Inc. (NYSE:ABBV) tops our list for being one of the most promising stocks. TheFly reported on February 4 that Evercore ISI lowered its price target on ABBV to $228 from $232 and maintained an Outperform rating. The firm noted that although Tremfya […] Feb 19, 2026 - $ABBV
What Analysts Think Is Changing The Ambev (BOVESPA:ABEV3) Story On Profit And Cash
Ambev's fair value estimate has been updated from R$13.98 to R$14.81, with the discount rate moving from 18.16% to 18.09% and revenue growth assumptions shifting from 4.60% to 5.13% in R$ terms. These changes reflect fresh research that puts more weight on how effectively the company might turn future revenue into earnings and, crucially, into cash by 2026. Continue reading this article to see how you can keep on top of these evolving assumptions and what they could mean for the ongoing... Feb 19, 2026 - $ABEV
Assessing Arcellx (ACLX) Valuation After New Anito Cel Safety Data And Shifting Analyst Views
Fresh laboratory data on Arcellx (ACLX) lead asset anito cel, presented at the TANDEM meeting, is in focus for investors as it highlights safety signals and coincides with shifting institutional and analyst views. See our latest analysis for Arcellx. Arcellx’s recent laboratory update and mixed analyst reactions come after a 22.92% decline in the 3 month share price return, even though the year to date share price return is 9% and the 3 year total shareholder return is very large. If this CAR... Feb 19, 2026 - $ACLX
How Safer-Looking CAR-T Data and Mixed Signals Will Impact Arcellx (ACLX) Investors
Recently released TANDEM meeting data showed that Arcellx’s lead CAR-T candidate, anitocabtagene autoleucel, exhibited lower unintended immune activity and fewer off-target effects than rival therapies, reinforcing its potentially differentiated safety profile. At the same time, insider selling by the CFO, a downgrade from one research house, and ongoing buy ratings from others highlight how the new safety data is being weighed against a crowded CAR-T competitive landscape. Next, we’ll... Feb 19, 2026 - $ACLX
Technip Energies announces the appointment of Jesse Stanley as President, Technologies & Products, and the new composition of its Executive Committee
Jesse Stanley Jesse Stanley President, Technologies & Products Technip Energies (PARIS: TE) today announces the appointment of Jesse Stanley as President, Technologies & Products (T&P) Business Unit and member of the Executive Committee as of March 16, 2026, as well as the new composition of its Executive Committee. Jesse Stanley, previously President, Operations Americas at Wood plc since 2024, will be joining Technip Energies as of March 16, 2026, as President, Technologies & Products and memb Feb 19, 2026 - $ACN
Barclays Adjusts ACV Auctions (ACV) Target Amid Momentum in Used Vehicle Market
ACV Auctions Inc. (NYSE:ACVA) is one of the best single digit stocks to buy according to analysts. On January 21, Barclays raised the firm’s price target on ACV Auctions to $8 from $7 and kept an Equal Weight rating as part of a Q4 2025 auto retail group outlook. Although the firm broadly lowered sector […] Feb 19, 2026 - $ACVA
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.